Literature DB >> 11998420

[Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak].

E Marc1, C Ménager, F Moulin, B Stos, M Chalumeau, S Guérin, P Lebon, F Brunet, J Raymond, D Gendrel.   

Abstract

OBJECTIVE: Viral meningitis are often treated with antibiotics in emergency because routine analysis of CSF is not always efficient for distinguishing between viral and bacterial infection. The aim of the study was to evaluate the usefulness of procalcitonin (PCT) to reduce antibiotic treatments. METHODS AND
RESULTS: A blood PCT level < 0.5 ng/mL was prospectively used for the diagnosis of viral origin of meningitis in 58 patients (two months-14 years), in which enterovirus was isolated by culture or PCR during an outbreak (May-June 2000). CSF cells range was 10 to 2800/mL (m: 244), PMN 5 to 2464/mL and CSF proteins range was 0.19 to 0.92 mg/dL (m: 0.37). Seventeen patients received antibiotic therapy in admission. In nine patients, PCT (dosage was routinely measured 3/week) result < 0.5 ng/mL was obtained in 24 h and in 48 h in six: treatment was then stopped and children led hospital. In two patients, PCT was > 1 ng/mL because of bacterial coinfection. CSF and PCT values were similar to those of an already published control group.
CONCLUSION: PCT dosage allowed to shorten hospitalization of 4.47 (controls) to 2.06 (patients) days in patients receiving unnecessary antibiotic treatments. During this outbreak, PCT dosage allowed to reduce 40 days of hospitalization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11998420     DOI: 10.1016/s0929-693x(01)00793-x

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  14 in total

Review 1.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

2.  Clinical decision rules to distinguish between bacterial and aseptic meningitis.

Authors:  F Dubos; B Lamotte; F Bibi-Triki; F Moulin; J Raymond; D Gendrel; G Bréart; M Chalumeau
Journal:  Arch Dis Child       Date:  2006-04-04       Impact factor: 3.791

Review 3.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

4.  A prospective bicenter study investigating the diagnostic value of procalcitonin in patients with acute appendicitis.

Authors:  Michael Sand; X V Trullen; F G Bechara; X F Pala; D Sand; G Landgrafe; B Mann
Journal:  Eur Surg Res       Date:  2009-08-07       Impact factor: 1.745

5.  Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy.

Authors:  Jean-Pierre Quenot; Charles-Edouard Luyt; Nicolas Roche; Martin Chalumeau; Pierre-Emmanuel Charles; Yann-Eric Claessens; Sigismond Lasocki; Jean-Pierre Bedos; Yves Péan; François Philippart; Stéphanie Ruiz; Christele Gras-Leguen; Anne-Marie Dupuy; Jérôme Pugin; Jean-Paul Stahl; Benoit Misset; Rémy Gauzit; Christian Brun-Buisson
Journal:  Ann Intensive Care       Date:  2013-07-08       Impact factor: 6.925

6.  Serum procalcitonin in viral and bacterial meningitis.

Authors:  Usama M Alkholi; Nermin Abd Al-Monem; Ayman A Abd El-Azim; Mohamed H Sultan
Journal:  J Glob Infect Dis       Date:  2011-01

Review 7.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Authors:  Philipp Schuetz; Werner Albrich; Beat Mueller
Journal:  BMC Med       Date:  2011-09-22       Impact factor: 8.775

8.  Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis.

Authors:  Alain Viallon; Nicolas Desseigne; Olivier Marjollet; Albert Birynczyk; Mathieu Belin; Stephane Guyomarch; Jacques Borg; Bruno Pozetto; Jean Claude Bertrand; Fabrice Zeni
Journal:  Crit Care       Date:  2011-06-06       Impact factor: 9.097

9.  Diagnostic value of serum procalcitonin level in differentiating bacterial from nonbacterial meningitis in children.

Authors:  Raid M R Umran; Nabeel Hashim Radhi
Journal:  Iran J Pediatr       Date:  2014-12-09       Impact factor: 0.364

10.  Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients?

Authors:  Yahya Shehabi; Ian Seppelt
Journal:  Crit Care       Date:  2008-05-02       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.